Cyteir Therapeutics, Inc.

Pharmaceutical company · Stoneham, Massachusetts, United States

Cyteir Therapeutics, Inc. is a pharmaceutical company headquartered in Stoneham, Massachusetts, United States. Its earliest recorded incorporation is in 2012. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.2 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $80 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Cyteir Therapeutics at a glance

Typepharmaceutical company
HeadquartersStoneham, Massachusetts, United States
Earliest incorporation on record2012
SEC industryPharmaceutical Preparations
Employees (per SBIR records)14
SEC CIK1662244

What does Cyteir Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.2 million in total (2014 to 2016). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $80 million sold (2021).

Frequently asked questions about Cyteir Therapeutics

Where is Cyteir Therapeutics headquartered?

Cyteir Therapeutics, Inc. is headquartered in Stoneham, Massachusetts, United States.

What does Cyteir Therapeutics do?

Cyteir Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Cyteir Therapeutics founded?

The earliest incorporation on record for Cyteir Therapeutics, Inc. is in 2012, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.